NEW YORK (GenomeWeb) – Genoptix has acquired the rights to market and distribute all of Rosetta Genomics' testing services worldwide, the companies announced today.

The deal comes as the firms try — for the second time — to close a merger that had previously failed to gain necessary approval from Rosetta shareholders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.